US2015004696A1PendingUtilityA1
Inhibiting cyclin d polypeptides
Est. expiryOct 10, 2026(~0.2 yrs left)· nominal 20-yr term from priority
G01N 33/566A61K 31/56G01N 33/6872A61K 31/573C07K 14/4738A61K 38/00A61K 31/7076
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This document involves methods and materials related to inhibiting cyclin D polypeptide activity. For example, this document provides methods and materials that can be used to (1) identify mammals or cells in need of cyclin D polypeptide inhibition and (2) administer an agent capable of inhibiting cyclin D polypeptide activity.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for reducing cyclin D polypeptide activity within a cell, wherein said method comprises:
(a) identifying a cell in need of reduced cyclin D polypeptide activity, and (b) administering an agent to said cell, wherein said agent is β-lapachone, dihydrogambogic acid, pristimerin, or kinetin riboside.Join the waitlist — get patent alerts
Track US2015004696A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.